Loading chat...
HI HCR39
Concurrent Resolution
Status
3/11/2026
Primary Sponsor
Tyson Miyake
Click for details
AI Summary
-
Urges the Hawaii Department of Health to coordinate stockpiling a three-year supply of mifepristone, the oral medication used in approximately 63% of abortions in the United States
-
Hawaii's Department of Health partnered with Kapiolani Medical Center for Women and Children in 2023 to maintain a one-year supply of mifepristone, which has a five-year shelf life
-
Approximately 3,900 abortions occurred in Hawaii in 2024, with 64% sought by individuals under 30 years of age as of 2022
-
In-person abortion care in Hawaii is currently only available on Maui and Oahu, limiting equitable access for neighbor island residents
-
Hawaii was the first state to legalize abortion in 1970, and the state constitution protects bodily autonomy and reproductive rights under Article I, Sections 3, 5, and 6
Legislative Description
Urging The Department Of Health To Coordinate The Stockpiling Of A Three-year Supply Of Mifepristone.
Department of Health
Last Action
Offered
3/12/2026